Enhanced Group CEO: Hot peptide summer is coming — but likely not till 2027

Thanks to our partner:Superpower - https://superpower.comMax's recent essays on peptides:https://maximilianbmartin.substack.com/p/six-peptides-one-signal-washingtonhttps://maximilianbmartin.substack.com/p/the-peptide-moment-is-here-enhancedIn episode 76 of Hims House, Jonathan Stern hosts Maximilian Martin, CEO of Enhanced Group ( $ENHA ), the newly public company behind the Enhanced Games and the Live Enhanced telehealth platform. Martin grades the inaugural games ten weeks out — 42 athletes, 21 personal bests, one world record, and $32M in contracted sponsorship — and argues the 40% stock price selloff that occurred after the Games is misplaced. He recounts his week in Washington D.C., around the FDA compounding advisory committee, where six of seven peptides were recommended, and explains why Enhanced will wait on FDA’s formal rulemaking to start selling peptides. He concedes peptides are essentially a “commodity”, so the edge has to come from brand and personalized protocols. Also covered: whether big pharma is quietly slowing things down, how big the market for peptides could be, and Enhanced’s recent supplements launch in 33 new countries. 00:00 - Sponsor: Superpower 
01:38 - The Enhanced Games: an honest scorecard
06:35 - Why $ENHA stock fell 40%
10:13 - The athlete-led flywheel
11:52 - Why he flew to Washington for peptides
18:07 - Six of seven peptides recommended
20:21 - How long will FDA rulemaking take? 
22:51 - Where the peptide moat actually is
30:16 - Is big pharma slowing down peptide approval?32:14 - Being first vs being best
40:33 - Could peptides be a $10B market in 2027? 
46:00 - Enhanced now live in 33 new markets
50:25 - Life as a public company CEODisclaimer: This podcast is for informational and entertainment purposes only. Nothing discussed should be considered financial, investment, or legal advice. Always consult with a qualified professional before making financial decisions.